Eur J Nucl Med Mol Imaging. 2026 Mar 7. doi: 10.1007/s00259-026-07830-5. Online ahead of print.
NO ABSTRACT
PMID:41792563 | DOI:10.1007/s00259-026-07830-5
Recent Content
- The [(18)F]FDG PET/CT for prognostic stratification in multiple myeloma: A systematic review and meta-analysis
- (no title)
- Teclistamab-daratumumab snag FDA approval in multiple myeloma
- Experimental therapy outperforms approved treatment in PNET trial
- (no title)
- New targeted therapy for childhood brain cancer nears European approval
- New trial data show alnodesertib may slow ovarian cancer progression
- (no title)
- IMF launches Myeloma Action Month to raise global awareness this March
- Cluster of differentiation 38 monoclonal antibody therapy in the treatment of multiple myeloma: a systematic review and meta-analysis